Blood pressure mystery: EPO's hidden side effect under the microscope
NCT ID NCT03810911
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 26 times
Summary
This study looked at why the drug erythropoietin (EPO), used to treat anemia in people with chronic kidney disease, can raise blood pressure. Researchers planned to compare blood pressure changes in patients who started EPO right away versus those who waited 12 weeks. The study was stopped early and only enrolled 27 out of 160 planned participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Richard L. Roudebush VA Medical Center, Indianapolis, IN
Indianapolis, Indiana, 46202-2884, United States
Conditions
Explore the condition pages connected to this study.